Oric Pharmaceuticals (ORIC)
(Delayed Data from NSDQ)
$10.67 USD
+0.57 (5.64%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $10.67 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | -7.14% |
ABR | 1.00 |
Earnings ESP
|
-4.53% |
---|---|
Current Year | -1.78 |
Next Year | -2.06 |
EPS (TTM) | -1.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.49 | -1.78 | -2.06 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.49 | -0.51 | -1.69 | -2.22 |
High Estimate | -0.43 | -0.44 | -1.69 | -1.96 |
Low Estimate | -0.52 | -0.53 | -1.87 | -2.22 |
Year ago EPS | -0.44 | -0.49 | -1.96 | -1.78 |
Year over Year Growth Est. | -9.09% | 0.00% | 9.18% | -15.49% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 3 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.49 | -1.78 | -2.06 |
7 Days Ago | -0.48 | -0.49 | -1.78 | -2.06 |
30 Days Ago | -0.47 | -0.49 | -1.78 | -2.08 |
60 Days Ago | -0.43 | -0.45 | -1.68 | -1.89 |
90 Days Ago | -0.43 | -0.45 | -1.68 | -1.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.51 | -1.84 | -1.96 |
Zacks Consensus Estimate | -0.48 | -0.49 | -1.78 | -2.06 |
Earnings ESP | -4.53% | -3.73% | -3.12% | 4.85% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.37 | -0.49 | -0.44 | NA |
Estimate | -0.42 | -0.44 | -0.49 | -0.46 | NA |
Difference | -0.03 | 0.07 | 0.00 | 0.02 | 0.02 |
Surprise | -7.14% | 15.91% | 0.00% | 4.35% | 3.28% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more